Recent Developments, Liquidity and Management’s Plans (Details Narrative) |
3 Months Ended | 9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 28, 2023
shares
|
Feb. 21, 2023
USD ($)
$ / shares
shares
|
Sep. 30, 2023
USD ($)
$ / shares
shares
|
Jun. 30, 2023
USD ($)
|
Mar. 31, 2023
USD ($)
|
Sep. 30, 2022
USD ($)
|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2022
USD ($)
|
Sep. 30, 2023
USD ($)
$ / shares
shares
|
Sep. 30, 2022
USD ($)
|
Dec. 31, 2022
USD ($)
$ / shares
|
Dec. 31, 2021
USD ($)
|
Apr. 16, 2021
$ / shares
|
|
Reverse stock split description | the Company effected a 1-for-2 reverse stock split of the issued and outstanding Company Common Stock | ||||||||||||
Share value new issues | $ 5,550,028 | ||||||||||||
Preferred stock dividends | $ 1,158,051 | $ 1,690,180 | |||||||||||
Derivative liability fair value | $ 3,149,800 | 898,100 | 898,100 | ||||||||||
Stock issuance costs | 314,311 | ||||||||||||
Fair value of the warrants | 10,623,000 | ||||||||||||
Change in fair value of Derivatives Liabilities | $ 2,566,900 | $ 2,251,700 | |||||||||||
Probability of default | 8.2 | 8.2 | |||||||||||
Preferred Stock Dividends, Shares | shares | 871,323 | 871,323 | |||||||||||
Dividends preferred stock | $ 766,503 | $ 766,503 | |||||||||||
Stock Issued During Period, Value, Conversion of Units | 2,347,852 | 4,695,704 | |||||||||||
Fair value of the warrants | 10,623,000 | ||||||||||||
Issuance of warrants | 762,834 | ||||||||||||
Change in fair value of Warrant Liabilities | (5,356,000) | (8,166,000) | |||||||||||
Fair value of warrants | 2,457,000 | 2,457,000 | |||||||||||
Cash on hand | 298,318 | 298,318 | 749,090 | ||||||||||
Marketable securities | 8,174,283 | 8,174,283 | 4,086,902 | ||||||||||
Loss from operations | 1,636,391 | ||||||||||||
Working capital | 4,040,337 | 4,040,337 | |||||||||||
Stockholders' equity | 15,500,682 | $ 10,741,770 | 13,094,059 | 18,327,047 | $ 16,118,343 | $ 19,622,140 | 15,500,682 | 18,327,047 | 14,695,056 | $ 23,647,174 | |||
Accumulated deficit | 97,085,475 | 97,085,475 | $ 93,758,904 | ||||||||||
Net cash provided by operating activities | 11,047,995 | 10,021,664 | |||||||||||
Net loss | (4,042,994) | 4,167,653 | 1,511,732 | 3,693,741 | 3,636,043 | 4,122,034 | 1,636,391 | 11,451,818 | |||||
Prepaid expenses | 697,691 | (113,217) | |||||||||||
Decrease in trade and other payables | 639,381 | (730,683) | |||||||||||
Fair value of the warrant liability | 10,417,700 | ||||||||||||
Share based compensation | 595,576 | 352,417 | 2,341,915 | 581,663 | |||||||||
Other Operating Income (Expense) [Member] | |||||||||||||
Change in fair value of Derivatives Liabilities | 2,566,900 | 2,251,700 | |||||||||||
Fair value of common stock on valuation date | 590,000 | 590,000 | |||||||||||
Change in fair value of Warrant Liabilities | $ 5,356,000 | $ 8,166,000 | |||||||||||
Measurement Input, Expected Dividend Rate [Member] | |||||||||||||
Estimated dividend rate | 10.00 | 10.00 | 10.00 | ||||||||||
Estimated Equity volatility | 130.00% | ||||||||||||
Fair value assumptions risk free interest rate | 5.49% | ||||||||||||
Measurement Input, Option Volatility [Member] | |||||||||||||
Estimated dividend rate | 120.00 | ||||||||||||
Stock price per share | 125.0 | 125.0 | |||||||||||
Measurement Input, Price Volatility [Member] | |||||||||||||
Estimated dividend rate | 190.00 | ||||||||||||
Measurement Input, Maturity [Member] | |||||||||||||
Time of maturity | 1 year 4 months 6 days | ||||||||||||
Measurement Input, Maturity [Member] | Other Operating Income (Expense) [Member] | |||||||||||||
Time of maturity | 9 months | ||||||||||||
Measurement Input, Discount Rate [Member] | |||||||||||||
Estimated dividend rate | 6.08 | ||||||||||||
Measurement Input, Lapse Rate [Member] | |||||||||||||
Estimated dividend rate | 15.00 | 15.00 | 15.00 | ||||||||||
Measurement Input, Default Rate [Member] | |||||||||||||
Estimated dividend rate | 0.05 | ||||||||||||
Measurement Input Volume Volatility [Member] | |||||||||||||
Estimated traded volume volatility | 120.0 | 120.0 | |||||||||||
Measurement Input, Expected Dividend Payment [Member] | |||||||||||||
Stock price per share | 0 | 0 | |||||||||||
Measurement Input, Risk Free Interest Rate [Member] | |||||||||||||
Stock price per share | 4.09 | 4.09 | |||||||||||
Series F Convertible Preferred Stock [Member] | |||||||||||||
Conversion price | $ / shares | $ 2.255 | ||||||||||||
Conversion of stock, description | (i) the Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the Company’s Common Stock during the thirty trading day period immediately prior to the date the amortization payment is due or (B) a “Floor Price” of $0.22 (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Stock Market. | If on any day after the issuance of the shares of Series F Preferred Stock the closing price of the Common Stock has exceeded 300% of the Conversion Price per share (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) for 20 consecutive trading days and the daily dollar trading volume of the Common Stock has exceeded $3,000,000 per trading day during the same period and certain equity conditions described in the Series F Certificate of Designation are satisfied (the “Mandatory Conversion Date”), we shall deliver written notice of the Mandatory Conversion (as defined below) to all holders on the Mandatory Conversion Date and, on such Mandatory Conversion Date, we shall convert all of each holder’s shares of Series F Preferred Stock into Conversion Shares at the then effective Conversion Price (the “Mandatory Conversion”). If any of the Equity Conditions shall cease to be satisfied at any time on or after the Mandatory Conversion Date through and including the actual delivery of all of the Conversion Shares to the holders, the Mandatory Conversion shall be deemed withdrawn and void ab initio. | |||||||||||
Share issued price, per share | $ / shares | $ 6.765 | ||||||||||||
Share value new issues | $ 3,000,000 | ||||||||||||
Preferred shares dividend rate | 10.00% | 10.00% | |||||||||||
Series F Convertible Preferred Stock [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||||||||
Preferred shares dividend rate | 15.00% | ||||||||||||
Series F Convertible Preferred Stock [Member] | Measurement Input, Default Rate [Member] | |||||||||||||
Preferred shares dividend rate | 15.00% | ||||||||||||
Securities Purchase Agreement [Member] | Investors [Member] | |||||||||||||
Number of shares issued | shares | 15,000 | ||||||||||||
Number of shares issued, value | $ 1,000 | ||||||||||||
Shares issued upon conversion | shares | 6,651,885 | ||||||||||||
Warrant exercise price | $ / shares | $ 2.255 | ||||||||||||
Warrants to purchase common stock | shares | 6,651,885 | ||||||||||||
Warrants term | 5 years | ||||||||||||
Warrant [Member] | |||||||||||||
Warrants shares | shares | 986,486 | 986,486 | |||||||||||
Warrants term | 5 years | 5 years | |||||||||||
Warrant [Member] | Measurement Input, Expected Dividend Rate [Member] | |||||||||||||
Stock price per share | 0 | 0 | |||||||||||
Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||||||||
Stock price per share | 4.66 | 4.66 | |||||||||||
Warrant [Member] | Measurement Input, Expected Term [Member] | |||||||||||||
Warrants term | 4 years 4 months 24 days | 4 years 4 months 24 days | |||||||||||
Warrant [Member] | Measurement Input Equity Volatility [Member] | |||||||||||||
Stock price per share | 115.0 | 115.0 | |||||||||||
Common Stock [Member] | |||||||||||||
Warrants shares | shares | 4,188,315 | 4,188,315 | |||||||||||
Share value new issues | 5,550,028 | ||||||||||||
Exercise price | $ / shares | $ 0.59 | $ 0.59 | $ 1.15 | ||||||||||
Issuance of preferred shares | shares | 73,776 | 4,101,909 | 6,450,122 | ||||||||||
Preferred Stock Dividends, Shares | shares | 871,323 | ||||||||||||
Stockholders' equity | $ 112,441,633 | 110,567,664 | 108,378,504 | 108,195,909 | 102,293,464 | 102,161,218 | $ 112,441,633 | 108,195,909 | $ 108,309,436 | 102,064,218 | |||
Net loss | |||||||||||||
Common Stock [Member] | Measurement Input, Exercise Price [Member] | |||||||||||||
Exercise price | $ / shares | $ 1.90 | ||||||||||||
Preferred Stock [Member] | |||||||||||||
Share value new issues | 14,087,111 | ||||||||||||
Derivative liability fair value | 3,149,800 | 3,149,800 | |||||||||||
Conversion of preferred stock | 152,149 | 304,296 | |||||||||||
Preferred Stock [Member] | Series F Convertible Preferred Stock [Member] | |||||||||||||
Share value new issues | 912,889 | ||||||||||||
Stockholders' equity | |||||||||||||
Net loss | |||||||||||||
Former MyMD Florida Equity Holders [Member] | |||||||||||||
Equity percentage | 77.05% | 77.05% | |||||||||||
Akers Bio Sciences Inc [Member] | |||||||||||||
Equity percentage | 22.95% | 22.95% | |||||||||||
MyMD Pharmaceuticals (Florida), Inc [Member] | |||||||||||||
Common stock, par value | $ / shares | $ 0.001 | ||||||||||||
Exchange ratio price per shares | $ / shares | $ 0.7718 |